In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
November 7th, 2005 | 16 | No |
(2R,3S)-2,3-Epoxy-4-oxo-7E,10E-dodecadienamide
(2R,3S)-3-((4E,7E)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide
(2R,3S)-3-((4E,7E)-nona-4,7-dienoyl)oxirane-2-carboxamide
(2r,3s)-3-(nona-4,7-dienoyl)oxirane-2-carboxamide
(2R,3S)-3-nona-4,7-dienoyloxirane-2-carboxamide
(2R,3S)-3-[(4E,7E)-nona-4,7-dienoyl]oxirane-2-carboxamide
(2R,3S,E,E)-2,3-Epoxy-4-oxo-7,10-dodecadienamide
(2R-(2alpha,3alpha(4E,7E)))-3-(1-Oxonona-4,7-dienyl)oxirane-2-carboxamide
(2S)(3R)-2,3-Epoxy-4-oxo-7,10-dodecadienoylamide
(2S,3R)-2,3-epoxy-4-oxy-7,10-dodecadienoylamide
(2S,3R)-2,3-epoxy-4-oxy-7,10-dodecadienoylamide; CPD-6901; cerulenin
2,3-Epoxy-4-oxo-7,10-dodecadienamide
2,3-Epoxy-4-oxo-7,10-dodecadienoylamide
3-(1-Oxo-4,7-nonadienyl)oxiranecarboxamide
3-nona-4,7-dienoyloxirane-2-carboxamide
3-[(4E,7E)-nona-4,7-dienoyl]oxirane-2-carboxamide
7,10-DODECADIENAMIDE, 2,3-EPOXY-4-OXO-
Cerulenin, Cephalosporium caerulens
cis-2-epoxy-4-oxo-7E,10E-dodecadienamide
Oxiranecarboxamide, 3-(1-oxo-4,7-nonadienyl)-, (2R-(2-alpha,3-alpha(4E,7E)))-
Oxiranecarboxamide, 3-(1-oxo-4,7-nonadienyl)-, (2R-(2-alpha,3-alpha(4E,7E)))- (9CI)
Oxiranecarboxamide, 3-(1-oxo-4,7-nonadienyl)-, (2R-(2alpha,3alpha(4E,7E)))-
Oxiranecarboxamide, 3-[(4E,7E)-1-Oxo-4,7-nonadienyl]-, (2R,3S)-
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 0.50 | 3.23 | -19.57 | 2 | 4 | 0 | 73 | 223.272 | 7 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 1.60e+00 g/l | DrugBank-approved |
UniProt Database Links | FABF_BACSU; FABH_ECO57; FABH_ECOL6; FABH_ECOLI; FABH_HAEIN; FABH_MYCTU; FABH_SPIOL; FABH_STRPN; FAS2_CANPC; FAS2_YEAST; LDB19_YEAST; MCA_MYCTU; OXSM_BOVIN; OXSM_HUMAN; OXSM_MOUSE; PRAF2_BOVIN; PRAF2_HUMAN; PRAF2_MACFA; PRAF2_MOUSE | ChEBI |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
FAS-2-E | Fatty Acid Synthase (cluster #2 Of 2), Eukaryotic | Eukaryotes | 5800 | 0.46 | Binding ≤ 10μM |
Q72874-2-V | Human Immunodeficiency Virus Type 1 Protease (cluster #2 Of 3), Viral | Viruses | 2500 | 0.49 | Binding ≤ 10μM |
Z50611-3-O | Moloney Murine Leukemia Virus (cluster #3 Of 3), Other | Other | 2700 | 0.49 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
FAS_HUMAN | P49327 | Fatty Acid Synthase, Human | 5800 | 0.46 | Binding ≤ 10μM |
Q72874_9HIV1 | Q72874 | Human Immunodeficiency Virus Type 1 Protease, 9hiv1 | 2500 | 0.49 | Binding ≤ 10μM |
Z50611 | Z50611 | Moloney Murine Leukemia Virus | 2700 | 0.49 | Functional ≤ 10μM |
Description | Species |
---|---|
Activation of gene expression by SREBF (SREBP) | |
ChREBP activates metabolic gene expression | |
Fatty Acyl-CoA Biosynthesis | |
Vitamin B5 (pantothenate) metabolism |